Key result
High-dose nafcillin linked to relative warfarin resistance via suspected enzyme induction.
Why the study?
Does high-dose nafcillin reduce the hypoprothrombinemic response to warfarin in patients receiving warfarin?
Case Report (n=3)
Does high-dose nafcillin reduce the hypoprothrombinemic response to warfarin in patients receiving warfarin?
High-dose nafcillin can induce warfarin resistance, requiring careful monitoring of anticoagulation to prevent subtherapeutic effects.
May warrant closer INR monitoring with high-dose nafcillin; leaves open confirmation of enzyme induction beyond case reports.
Patients who are receiving multiple medications must be screened for significant drug interactions. The specific mechanism of a drug interaction determines whether the patient may experience a subtherapeutic effect or a potentially toxic reaction. Three cases of relative warfarin resistance, possibly related to high-dose nafcillin, are described in this report. Several reports have suggested that penicillinase-resistant penicillins, such as nafcillin and dicloxacillin, exert an important enzyme-inducing effect in patients receiving warfarin. This potential interaction must be appropriately recognized and managed in order to maintain adequate anticoagulation in this patient population.
No takes yet. Share an insight, caveat, or question.
Shovick et al. (1991) conducted a case report in Relative warfarin resistance (n=3). High-dose nafcillin was evaluated on Relative warfarin resistance (decreased hypoprothrombinemic response). High-dose nafcillin was associated with relative warfarin resistance in three reported cases, suggesting an important enzyme-inducing effect.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: